Masataka Ichikawa

3.4k citations
146 papers · 2.5k indexed · h-index 25
Topics
Synthesis and biological activity (22 papers)Influenza Virus Research Studies (19 papers)Synthesis and Characterization of Heterocyclic Compounds (19 papers)
Partner nations
JapanUnited StatesUganda

In The Last Decade

Masataka Ichikawa

132 papers receiving 2.3k citations

Peers

Masataka Ichikawa
Comparison fields: 5 of 127
  • Epidemiology 811
  • Molecular Biology 638
  • Organic Chemistry 460
  • Oncology 250
  • Pharmaceutical Science 240
Replace Toru Kino with:
Toru Kino Japan
Gerhard Hamilton Austria
Shuang Li China
Jeffrey A. Silverman United States
Mayland Chang United States
Arlene S. Bridges United States
Hamidreza Montazeri Aliabadi United States
Thomas A. Krenitsky United States
Sylvie Fournel France
Michael J. Kelso Australia
Masataka Ichikawa relative to Toru Kino Japan Toru Kino's profile →
Citations per field
00.5×4.0×
Toru Kino · 1×
Citations per year

Countries citing papers authored by Masataka Ichikawa

Since Specialization
Citations

This map shows the geographic impact of Masataka Ichikawa's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Masataka Ichikawa with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Masataka Ichikawa more than expected).

Fields of papers citing papers by Masataka Ichikawa

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Masataka Ichikawa. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Masataka Ichikawa. The network helps show where Masataka Ichikawa may publish in the future.

Co-authorship network of co-authors of Masataka Ichikawa

This figure shows the co-authorship network connecting the top 25 collaborators of Masataka Ichikawa. A scholar is included among the top collaborators of Masataka Ichikawa based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Masataka Ichikawa. Masataka Ichikawa is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 1
2 7
3 10
4 34
5 12
6 32
7 28
8 131
9 1
10 19
11 3
12 2
13
In Vivo Ocular Pharmacokinetic Model for Designing Dosage Schedules and Formulations of Ophthalmic Drugs in Human
8
14 2
15 0
16 7
17 26
18 30
19 1
20
Carcinogenicity of 2-(2-furyl)-3-(5-nitro-2-furyl)acrylamide (AF-2) fed to female Sprague-Dawley rats.
4

About Masataka Ichikawa

Masataka Ichikawa is a scholar working on Pharmaceutical Science, Organic Chemistry and Toxicology, having authored 146 papers that have together received 2.5k indexed citations. Recurring topics across this work include Synthesis and biological activity (22 papers), Influenza Virus Research Studies (19 papers) and Synthesis and Characterization of Heterocyclic Compounds (19 papers). The work is most often cited by research in Pharmaceutical Science (240 citations), Epidemiology (811 citations) and Organic Chemistry (460 citations). Masataka Ichikawa has collaborated with scholars based in Japan, United States and Uganda. Frequent co-authors include T. HISANO, Keiko Mitamura, Masahiko Yamazaki, Chiharu Kawakami, Hitoshi Sasaki, Junzo Nakamura, Kenzo Yamamura, Norio Sugaya, Koyo Nishida and Mikiro Nakashima. Their work appears in journals such as JAMA, Journal of Clinical Oncology and Clinical Infectious Diseases.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026